Miguel Ondetti
For developing an innovative approach to drug design based on protein structure and using it to create the ACE inhibitors, powerful oral agents for the treatment of high blood pressure, heart failure, and diabetic kidney disease.
Affiliated at time of winning
Bristol-Myers Squibb Pharmaceutical Research Institute
Princeton, United States